Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.52 +0.14%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
NEOV, MANU, CTAS, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
NEOV, MANU, CTAS, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- AutoZone (AZO) Tops Q4 EPS by $1.76, Misses on Revenue
- Societe Generale SA (GLE:FP) (SCGLY) PT Raised to EUR83 at JPMorgan
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
